ATE39927T1 - -9-fluoro-6,7-dihydro-5-methyl-1-oxo-8 substituierte-1h,5h-benzo (ij>-chinolizin-2carboxyl-s|ure; ihre derivate und verfahren zu ihrer herstellung. - Google Patents

-9-fluoro-6,7-dihydro-5-methyl-1-oxo-8 substituierte-1h,5h-benzo (ij>-chinolizin-2carboxyl-s|ure; ihre derivate und verfahren zu ihrer herstellung.

Info

Publication number
ATE39927T1
ATE39927T1 AT85305125T AT85305125T ATE39927T1 AT E39927 T1 ATE39927 T1 AT E39927T1 AT 85305125 T AT85305125 T AT 85305125T AT 85305125 T AT85305125 T AT 85305125T AT E39927 T1 ATE39927 T1 AT E39927T1
Authority
AT
Austria
Prior art keywords
fluoro
benzo
dihydro
oxo
methyl
Prior art date
Application number
AT85305125T
Other languages
English (en)
Inventor
Thomas F Mich
Townley P Culbertson
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE39927T1 publication Critical patent/ATE39927T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT85305125T 1984-07-20 1985-07-18 -9-fluoro-6,7-dihydro-5-methyl-1-oxo-8 substituierte-1h,5h-benzo (ij>-chinolizin-2carboxyl-s|ure; ihre derivate und verfahren zu ihrer herstellung. ATE39927T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/632,999 US4550103A (en) 1984-07-20 1984-07-20 Antibacterial 1-oxo-benzoquinolizine-2-carboxylic acids
EP85305125A EP0174077B1 (de) 1984-07-20 1985-07-18 -9-fluoro-6,7-dihydro-5-methyl-1-oxo-8 substituierte-1H,5H-benzo [ij]-chinolizin-2-carboxyl-Säure; ihre Derivate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE39927T1 true ATE39927T1 (de) 1989-01-15

Family

ID=24537866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85305125T ATE39927T1 (de) 1984-07-20 1985-07-18 -9-fluoro-6,7-dihydro-5-methyl-1-oxo-8 substituierte-1h,5h-benzo (ij>-chinolizin-2carboxyl-s|ure; ihre derivate und verfahren zu ihrer herstellung.

Country Status (5)

Country Link
US (1) US4550103A (de)
EP (1) EP0174077B1 (de)
JP (1) JPS6163677A (de)
AT (1) ATE39927T1 (de)
DE (1) DE3567462D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4638067A (en) * 1982-09-09 1987-01-20 Warner-Lambert Co. Antibacterial agents
US4617308A (en) * 1985-01-25 1986-10-14 Warner-Lambert Company 7-substituted amino-1-aryl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and derivatives thereof as antibacterial agents
CA2081210C (en) * 1991-03-22 2000-09-19 Edwin Boudreaux Jr. Glass-reinforced grafted branched higher alpha-olefins
US5347017A (en) * 1993-07-07 1994-09-13 Warner-Lambert Company Process for chiral 3-(1-amino-1,1-bisalkylmethyl)-1-substituted-pyrrolidines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
PH22140A (en) * 1982-06-29 1988-06-01 Daiichi Seiyaku Co Tricyclic compounds
US4472406A (en) * 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives

Also Published As

Publication number Publication date
DE3567462D1 (en) 1989-02-16
JPS6163677A (ja) 1986-04-01
US4550103A (en) 1985-10-29
EP0174077B1 (de) 1989-01-11
EP0174077A1 (de) 1986-03-12

Similar Documents

Publication Publication Date Title
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
ES8507535A1 (es) Acidos 7-amino-1-ciclopropil-6,8-difluor-1,4-dihidro-4-oxo-quinolincarboxilicos
TW289020B (de)
ATE44954T1 (de) Carbostyrilderivat und verfahren zu seiner herstellung.
ATE25245T1 (de) Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel.
IE863104L (en) Quinolone derivatives
EP0266576A3 (de) 1-Tert-alkyl-substituierte Naphthyridin- und Chinolincarbonsäure als antibakterielle Mittel
ATE2952T1 (de) Substituierte n-benzoylanthranilsaeurederivate und deren anhydroverbindungen, verfahren zu ihrer herstellung und ihre verwendung als herbizide und mittel dafuer.
EP0181588A3 (de) Alkyl-l-cyclopropyl-l,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
DE2967701D1 (de) A-21978 genannte antibiotische mischung, verfahren zu ihrer herstellung, ihre pharmazeutischen zusammensetzungen und produzierender mikroorganismus.
ES8500931A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
EP0230053A3 (de) 7-(Substituierte)Piperazinyl-1-äthyl-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarbonsäure
FR2484418B1 (fr) Nouveaux derives d'acide isocyanurique, utiles notamment comme agents cytostatiques, et leur procede de preparation
DE59009705D1 (de) Verfahren zur Herstellung von 2,7-Diazabicyclo(3.3.0)octanen.
SE9300758D0 (sv) Process for the production of clavulanic acid
ATE1609T1 (de) Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE39927T1 (de) -9-fluoro-6,7-dihydro-5-methyl-1-oxo-8 substituierte-1h,5h-benzo (ij>-chinolizin-2carboxyl-s|ure; ihre derivate und verfahren zu ihrer herstellung.
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
BE887752A (fr) Derives de l'acide 7-oxo-1-azabicyclo (3,2,0) hept-2-ene-2-carboxylique, leur procede de preparation et leur application notamment comme antibiotiques
ATE32897T1 (de) Pyrazolo(3,4,5-kl)acridinderivate, pharmazeutische zubereitungen die sie enthalten und verfahren zu ihrer herstellung.
ATE77621T1 (de) 3-perfluoroalkyl-isoxazol-5-yl-oxycarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als herbizide.
ATE236131T1 (de) Optisch aktives 2-nitroimidazolderivat, verfahren zu seiner herstellung und ein intermediat zu seiner herstellung
ATE647T1 (de) 2-amino-8-cyclopropyl-5-oxo-5,8-dihydro-pyrido (2,3-d) pyrimidin-6-carbonsaeuren, sie enthaltende arzneimittel sowie verfahren zu ihrer herstellung.
DE3861271D1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee